U.S. market Closed. Opens in 17 hours 20 minutes

NVS | Novartis AG Stock Fundamentals

(Stock Exchange: NYSE)
Analyzing fundamentals for NVS we got that it has strong fundamentals where Valuation is considered to be significantly undervalued, Profitability is very wealthy, Growth is good and Health is strong.

Valuation (81%)

Company Industry
P/E Ratio (TTM) 14.54 48.27
PEG Ratio (TTM) 0.12 5.21
P/S Ratio (TTM) 4.70 9.23
P/B Ratio (TTM) 5.64 26.30
P/FCF Ratio (TTM) 19.33 -50.04
Price to 5YR AVG Earnings Ratio 20.88 62.73
Price to 5YR AVG FCF Ratio 19.58 96.25

Profitability (80%)

Company Industry
ROA (TTM) 16.59% 8.52%
ROE (TTM) 38.92% 36.23%
Net Profit Margin (TTM) 33.55% 17.02%
ROIC 5YR AVG 16.95% 20.80%

Growth (63%)

4QTR AVG 3YR AVG 5YR AVG
EPS 79.18% 57.79% 45.46%
Revenue -2.41% 0.01% -2.38%
Net Income 77.51% 55.73% 41.93%
Cash Flow 25.48% 2.02% 0.42%

Health (65%)

Company Industry
Current Ratio (TTM) 0.93 1.10
Quick Ratio (TTM) 0.72 0.87
D/E Ratio (TTM) 0.66 2.87
Interest Coverage (TTM) 13.14 13.86
Piotroski F-Score 8 6
Altman Z-Score 4.18 5.00
LTL to 5YR AVG FCF 1.73 4.11
Shares Outstanding Growth 5YR AVG -2.17% 1.15%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙